vTv Therapeutics
VTVT
20 hedge funds and large institutions have $1.28M invested in vTv Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
5% less funds holding
Funds holding: 21 → 20 (-1)
5.15% less ownership
Funds ownership: 8.43% → 3.27% (-5.2%)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
63% less capital invested
Capital invested by funds: $3.4M → $1.28M (-$2.13M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$473K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$61.2K |
| 3 |
VF
Virtu Financial
New York
|
+$43.8K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$40.2K |
| 5 |
BlackRock
New York
|
+$20K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$2.1M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$382K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$40.6K |
| 4 |
Barclays
London,
United Kingdom
|
-$35.1K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$30K |
VTVT Hedge Fund Activity: Q2 2019 in Review
20 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q2 2019, worth a combined $1.28M — down 63% from $3.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of VTVT and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.
The largest buyer was Bank of America, adding an estimated $473K. The largest seller was CVI Holdings, exiting entirely with an estimated $2.1M sold.
- 20 institutional investors held vTv Therapeutics (VTVT) as of Q2 2019, down from 21 in Q1 2019.
- Funds reported $1.28M of vTv Therapeutics stock for Q2 2019, down 63% quarter-over-quarter.
- 3 funds opened new vTv Therapeutics positions in Q2 2019 and 4 closed out, a net change of -1 holder.
- The largest vTv Therapeutics buyer in Q2 2019 was Bank of America, an estimated $473K added.
- The largest vTv Therapeutics seller in Q2 2019 was CVI Holdings, an estimated $2.1M sold.
Based on aggregated 13F filings for Q2 2019.